Financial Daily from THE HINDU group of publications
Friday, Jul 16, 2004

Cross Currency

Group Sites

Corporate - Corporate Bonds

Natco Pharma plans foreign bonds issue

Our Bureau

Hyderabad , July 15

NATCO Pharma Ltd has informed the stock exchanges that a meeting of its board of directors would be held on July 23 to consider issue of Foreign Currency Convertible Bonds (FCCBs) and also Employees Stock Option Scheme (ESOS).

More Stories on : Corporate Bonds | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Biocon to pay 20%

Scorpio launched in Kuwait
`Birlas hold over 60 pc in Pilani Investment'
We're united in securing Estate for charity: Birlas
Legal heir issue may open pandora's box
Birlas yet to get copy of will from Lodha
Rating agencies watching Birla case keenly
Warwick honours Venu Srinivasan
Tulip agrees to clear VRS dues for Centaur staff
Natco Pharma plans foreign bonds issue
Emerging Markets acquires 5.6 pc stake in Birla Corp
GAIL in talks to pick 26% in Ennore project
Coromandel Fert plans Rs 40-cr expansion at Vizag
Reliance proposes mega power plant in Kakinada
Carrera plans $130-m textile project in India
FIR filed against Top Line Shoes directors
Metropolis ropes in hospitals to tap global clinical trials biz
Retail, shipping business — Govt turns down ONGC's joint venture proposal
Woolmark, Resil pact for new technology
Woolmark to focus on marketing, structural skill
Murugappa Group plans community initiatives in AP
Indo Rama plans foray into grocery retail
ISO certification for KAL
Samkrg Pistons gets QMS certification
Kerala signs pact for TRL revival
Whirlpool upbeat on exports — Converts part of Pondy facility into EoU
Karan Paul is new Apeejay group chief
Santanu Mallick appointed as Star News CFO

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line